Open Tender Watch
Menu v
ACCESS EN PT
← Companies Company PT

RATIOPHARM - COMÉRCIO E INDÚSTRIA DE PRODUTOS FARMACÊUTICOS LDA

NIF 502414910
↓ CSV ↓ JSON
Risk Flags
A1 · Repeat Direct Award €2,913,686 52 contracts
Same supplier receives ≥2 direct awards in 36 months with cumulative value above the CCP Art. 113 §2 statutory cap
HIGH €2,913,686 52 contracts
A2 · Late Publication €1,149,581,120 1,204 contracts
Contract published to BASE more than 10 days after the signing date
LOW €1,149,581,120 1,204 contracts
A5 · Threshold Splitting €1,971,371 30 contracts
Contract value falls within 5% below a procedural threshold (€5K / €20K / €75K / €150K / €5.35M). Score: 35 · Severity: Medium.
HIGH €1,971,371 30 contracts
A9 · Abnormal Price Reduction €1,374,705,543 725 contracts
Effective price exceeds base price by >50% (score 30) or >100% (score 55); or effective price is <50% of base (score 10, possible predatory bid or data error). Severity: Medium/High/Low.
LOW €1,374,705,543 725 contracts
C3 · Missing Mandatory Fields €62,185 8 contracts
CPV code, procedure type, or base price absent for the procedure type, or base price exceeds ±€1 trillion (implausible data entry). Score: 20 · Severity: Low.
LOW €62,185 8 contracts

Procurement Network

Aggregated links between this entity and connected counterparties

Public view excludes person-level links and tax identifiers.

Loading network…
Legend Focus entity Public body Company Anonymized individual

Contracts by Contracting Authority

155
€91,380,922
9
€67,445,581
24
€67,010,616
55
€65,955,049
15
€65,725,583
305
€53,431,776
26
€50,468,025
11
€50,084,400
30
€50,000,408
20
€49,837,630
8
€48,624,342
9
€47,985,013
12
€47,758,852
53
€46,996,137
9
€46,976,271
48
€46,941,437
24
€46,924,736
2
€46,782,337
15
€46,729,077
40
€46,727,187
Page 1 of 4 · 63 authorities
Next →

All Contracts Won

Signal: All A1 · Repeat Direct Award A2 · Late Publication A5 · Threshold Splitting A9 · Abnormal Price Reduction C3 · Missing Mandatory Fields

Page 1 of 1 · 8 contracts

COTRIMOXAZOL 800160MG COMP (PC.04167.2024)
PT · 11154952 · Ao abrigo de acordo-qu...
C3 · Missing Mandatory Fields
€134 2024-12-11
31/384/2025 - Medicamento "Sulfametoxazol + Trimetoprim"
PT · 11261511 · Ao abrigo de acordo-qu...
C3 · Missing Mandatory Fields
€686 2024-12-05
Medicamentos anti-infeciosos
PT · 11261450 · Ao abrigo de acordo-qu...
C3 · Missing Mandatory Fields
€654 2024-10-25
Aquisição de Medicamentos Diversos ao abrigo de vários Acordos Quadro, AQ 21/2020, 55/2021, 61/2021, 40/2022,55/2022, 173/2022 E 481/2023.
PT · 11236876 · Ao abrigo de acordo-qu...
C3 · Missing Mandatory Fields
€6,859 2024-08-07
Aquisição de Medicamentos Diversos (CP 2022/55)
PT · 11348303 · Ao abrigo de acordo-qu...
C3 · Missing Mandatory Fields
€14,230 2024-05-17
Aquisição de Medicamentos Diversos SPMS 2022/55
PT · 11225011 · Ao abrigo de acordo-qu...
C3 · Missing Mandatory Fields
€9,551 2024-03-21
Aquisição de Medicamentos Diversos 2
PT · 11743785 · Ao abrigo de acordo-qu...
C3 · Missing Mandatory Fields
€26,655 2024-02-27
MEDICAMENTOS DIVERSOS AQ 2020/5
PT · 11232248 · Ao abrigo de acordo-qu...
C3 · Missing Mandatory Fields
€3,412 2024-01-04
Overview
Total Value Won
€1,386,198,055
Contracts Won
1,616
Score 59220 · CRITICAL RISK
NIF
502414910
Country
PT
Directors & Officers

Personal data is pseudonymised for public access. Authenticate with a journalist token to view full names and NIFs.

  • A.R. [P-c0e8]
    Gerente
    since 2021-08-06
  • C.A. [P-7b29]
    Gerente
    since 2010-09-14
  • C.A. [P-7b29]
    Gerente
    since 2016-07-13
  • I.C. [P-f445]
    Gerente
    since 2015-06-02
  • I.C. [P-f445]
    Gerente
    since 2016-07-13
  • I.C. [P-f445]
    Gerente
    since 2017-10-12
  • M.M. [P-98f9]
    Gerente
    since 2015-06-02
  • M.M. [P-98f9]
    Gerente
    since 2016-07-13
  • M.G. [P-1218]
    Gerente
    since 2020-01-24
  • M.S. [P-7e53]
    Gerente
    since 2025-05-14
  • P.A. [P-4562]
    Gerente
    since 2014-07-02
  • P.A. [P-4562]
    Gerente
    since 2016-07-13
  • P.A. [P-4562]
    Gerente
    since 2017-10-12
  • V.J. [P-7f58]
    Gerente
    since 2025-05-14
  • C.A. [P-7b29]
    Gerente
    2017-10-12 → 2021-08-06
  • E.B. [P-4125]
    Gerente
    2014-07-02 → 2015-06-02
  • I.C. [P-f445]
    Gerente
    2023-05-03 → 2025-05-30
  • M.M. [P-98f9]
    Gerente
    2017-10-12 → 2020-01-24
  • P.M. [P-976f]
    Gerente
    until 2010-07-27
  • T.J. [P-219a]
    Gerente
    2010-09-14 → 2014-05-06
  • W.G. [P-58e0]
    Gerente
    until 2010-08-30
Ownership & Registries

Beneficial ownership data (shareholders, directors, ultimate beneficial owners) is not yet imported. Links below open external public registries.

Registo Comercial (MJ) ↗ RCBE — Beneficial Ownership Register ↗

Full RCBE access requires judicial authentication (CJEU 2022 ruling limits public exposure).

Search in TED (EU procurement) ↗
Phase 7 — ownership layer planned